Robert C. Quackenbush

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 898 citations

Medicine, Oncology, Pharmacology +14

Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow

Warren S. Pear, Juli P. Miller, Lanwei Xu et al. · Blood · 1998 · 738 citations

Medicine, Hematology, Oncology +12

Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway

Zonghan Dai, Robert C. Quackenbush, Kevin D. Courtney et al. · Genes & Development · 1998 · 113 citations · Full text

Medicine, Molecular Biology, Oncology +15

Neutrophilic‐chronic myeloid leukemia

Srđan Verstovšek, Hui Lin, Hagop M. Kantarjian et al. · Cancer · 2002 · 70 citations

Medicine, Hematology, Molecular Biology +16

Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases

Robert C. Quackenbush, Gary W. Reuther, Juli P. Miller et al. · Blood · 2000 · 65 citations

Medicine, Molecular Biology, Oncology +8